Page last updated: 2024-08-21

indazoles and pi103

indazoles has been researched along with pi103 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alix, S; Box, G; Chuckowree, I; Clarke, PA; De Haven Brandon, A; Di Stefano, F; Eccles, SA; Folkes, A; Gowan, S; Hayes, A; Henley, AT; Lensun, L; McDonald, E; Patel, S; Pergl-Wilson, G; Raynaud, FI; Robson, A; Saghir, N; Sheldrake, P; Shuttleworth, S; Valenti, M; Wan, NC; Workman, P; Zhyvoloup, A1
Clarke, PA; Raynaud, FI; van Montfort, RL; Workman, P1
Mansley, MK; Wilson, SM1
Dittmann, K; Fulda, S; Graab, U; Hahn, H; Marklein, D; Naumann, I; Nitzki, F; Ridzewski, R; Rosenberger, A; Wienands, J; Wojnowski, L; Yan, T1

Reviews

1 review(s) available for indazoles and pi103

ArticleYear
Drugging the PI3 kinome: from chemical tools to drugs in the clinic.
    Cancer research, 2010, Mar-15, Volume: 70, Issue:6

    Topics: Animals; Drug Delivery Systems; Furans; Humans; Indazoles; Models, Molecular; Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Sulfonamides

2010

Other Studies

3 other study(ies) available for indazoles and pi103

ArticleYear
Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941.
    Molecular cancer therapeutics, 2009, Volume: 8, Issue:7

    Topics: Administration, Oral; Animals; Cell Proliferation; Cells, Cultured; Endothelium, Vascular; Enzyme Inhibitors; Female; Furans; Glioblastoma; Humans; Indazoles; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinases; Pyridines; Pyrimidines; Sulfonamides; Thiophenes; TOR Serine-Threonine Kinases; Umbilical Veins; Xenograft Model Antitumor Assays

2009
Effects of nominally selective inhibitors of the kinases PI3K, SGK1 and PKB on the insulin-dependent control of epithelial Na+ absorption.
    British journal of pharmacology, 2010, Volume: 161, Issue:3

    Topics: Absorption; Androstadienes; Animals; Benzoates; Benzylamines; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Epithelial Cells; Furans; Immediate-Early Proteins; Indazoles; Insulin; Ion Transport; Kidney Tubules, Collecting; Membrane Potentials; Mice; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Pyridines; Pyrimidines; Quinoxalines; Sodium; Sulfonamides; Wortmannin

2010
PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cells.
    PloS one, 2012, Volume: 7, Issue:12

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cytochromes c; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Furans; Gene Expression; Humans; Indazoles; Mice; Mice, Nude; Multidrug Resistance-Associated Proteins; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pyridines; Pyrimidines; Sarcoma; Sulfonamides; TOR Serine-Threonine Kinases; Tumor Burden; Xenograft Model Antitumor Assays

2012